Abstract 3136: EOS-215, a first-in-class TREM2 antagonist, designed to reprogram the tumor microenvironment and overcome resistance

Authors: Thibaut Janss, Romain Pirson, Virginie Rabolli, Iain Welsby, Clotilde Hoyos, Quentin Dubray, Laura Saerens, Jean-Philippe Deglasse, David Carbonez, Lennart Raman, Francesco Strozzi, Julie Chesne, Joao Matos Marchante, Reece Marillier, Yvonne McGrath, Catherine Hoofd

Published: 2025-04-21

DOI: 10.1158/1538-7445.am2025-3136

Source: Full article